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Abstract
Background: The HE2 gene encodes a group of isoforms with similarities to the antimicrobial
beta-defensins. We demonstrated earlier that the antimicrobial activity of HE2 proteins and
peptides is salt resistant and structure dependent and involves permeabilization of bacterial
membranes. In this study, we further characterize the antimicrobial properties of HE2 peptides in
terms of the structural changes induced in E. coli and the inhibition of macromolecular synthesis.
Methods: E. coli treated with 50 micro g/ml of HE2alpha, HE2beta1 or HE2beta2 peptides for 30
and 60 min were visualized using transmission and scanning electron microscopy to investigate the
impact of these peptides on bacterial internal and external structure. The effects of HE2alpha,
HE2beta1 and HE2beta2 on E. coli macromolecular synthesis was assayed by incubating the
bacteria with 2, 10 and 25 micro g/ml of the individual peptides for 0–60 min and measuring the
incorporation of the radioactive precursors [methyl-3H]thymidine, [5-3H]uridine and L-[4,5-
3H(N)]leucine into DNA, RNA and protein. Statistical analyses using Student's t-test were
performed using Sigma Plot software. Values shown are Mean ± S.D.
Results:  E. coli treated with HE2alpha, HE2beta1 and HE2beta2 peptides as visualized by
transmission electron microscopy showed extensive damage characterized by membrane blebbing,
thickening of the membrane, highly granulated cytoplasm and appearance of vacuoles in contrast to
the smooth and continuous membrane structure of the untreated bacteria. Similarly, bacteria
observed by scanning electron microscopy after treating with HE2alpha, HE2beta1 or HE2beta2
peptides exhibited membrane blebbing and wrinkling, leakage of cellular contents, especially at the
dividing septa, and external accumulation of fibrous materials. In addition, HE2alpha, HE2beta1 and
HE2beta2 peptides inhibited E. coli DNA, RNA and protein synthesis.
Conclusions:  The morphological changes observed in E. coli treated with epididymal HE2
peptides provide further evidence for their membrane dependent mechanism of antibacterial
action. HE2 C-terminal peptides can inhibit E. coli macromolecular synthesis, suggesting an
additional mechanism of bacterial killing supplementary to membrane permeabilization.
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Introduction
Antimicrobial proteins and peptides are widely expressed
in both plants and animals. A variety of natural antibiotics
belonging to different classes such as defensins, cathelici-
dins, cercopins and protease inhibitors [1] are found in
epithelial tissues of organs that are most likely exposed to
pathogens. Among them, the most studied in humans are
the defensins, which are broadly classified into three types
viz alpha, beta and theta defensins depending on their
disulfide bonding, tissue distribution and genomic organ-
ization. They exhibit broad spectrum antimicrobial activ-
ity [2-5], thus may form an important component of the
innate immune system. Antimicrobial proteins and pep-
tides including defensins are generally cationic in nature
[6] and are believed to exert their bactericidal effect by
permeabilizing the bacterial membranes by forming pores
[7], thinning the membrane [8], or by destabilizing the
membrane bilayer [9]. In addition to membrane permea-
bilization, antimicrobial proteins and peptides kill bacte-
ria by inhibition of macromolecular biosynthesis [10-12]
and/or interacting with specific vital components inside
the bacteria [13,14].
In the epididymis, a major organ of the male reproductive
tract, immature sperm released from the testis undergo
sequential maturation to acquire forward motility and fer-
tilizing ability. A wide variety of proteins including anti-
microbial proteins released into the lumen of epididymis
bind sperm and are thought to play an important role in
epididymal immunity in addition to their role in sperm
maturation [15]. Examples of antimicrobial proteins
reported in the male reproductive tract include human
cationic antimicrobial protein (hCAP18, a cathelicidin)
[16], defensins [17-20], the epididymal β-defensin mem-
ber Bin1b [21], cystatins [22,23], lactoferrin [24] seminal-
plasmin [25] and seminogelin-derived peptides [26].
Earlier we identified and characterized the sperm binding
epididymal proteins of the HE2 family [27], which show
homology to the antimicrobial β-defensins. The HE2 gene
located on chromosome 8p23 within the β-defensin gene
cluster, encodes a series of isoforms containing identical
proregions joined to different C-terminal peptides [27].
Among them, HE2β1 conserves the characteristic β-
defensin-like six-cysteine motif (Figure 1). Furthermore,
like the β-defensins, HE2 C-terminal peptides are cleaved
from their proregions by a furin-like proprotein conver-
tase and these peptides are reported to exist in the epidi-
dymal epithelium, luminal fluid and the seminal plasma
[28]. We demonstrated the antimicrobial activity of
HE2α, HE2β1 and HE2β2 proteins and their C-terminal
peptides [29] and the epididymis specific defensin
DEFB118 [30] against E. coli. Their antimicrobial activities
are structure dependent and salt tolerant and their mech-
anism of action involves interacting with and permeabi-
lizing bacterial membranes. However, structural evidence
for the membrane changes in E. coli induced by these pep-
tides is still lacking. Further, it is not still clear whether
bacterial killing by HE2 peptides involves only membrane
permeabilization or whether the peptides interact with
specific targets inside the bacteria to inhibit metabolic
processes as reported for other antimicrobial proteins is
not yet demonstrated. In this study, using transmission
and scanning electron microscopy, we provide further evi-
dence that HE2 peptides induce significant structural
changes in E. coli consistent with their membrane
dependent mechanism of action as reported earlier. Fur-
ther, we show that HE2 peptides inhibit E. coli DNA, RNA
and protein synthesis suggesting that their antimicrobial
action may also involve targets inside the bacteria as well
as membrane permeabilization.
Methods
Recombinant peptide preparation and synthesis
HE2α and HE2β2 C-terminal peptides were synthesized at
the Peptide Synthesis Facility, University of North Caro-
lina, Chapel Hill by standard f-moc solid phase proce-
dures using Rainin symphony multiple peptide
synthesizer (Rainin Instrument, Woburn, MA). The puri-
fied peptides eluted as single peaks upon reverse phase
high performance liquid chromatography (HPLC) and
were further demonstrated to have their corresponding
molecular weight by MALDI-TOF mass spectrometry.
HE2β1 C-terminal peptide was expressed in E. coli and
purified as described previously [29]. Briefly, E. coli strain
M15 (pREP4) was transformed with pQE30 vector (Qia-
gen, Valencia, CA, U.S.A) containing cDNA that codes for
HE2β1 C-terminal peptide. Protein expression was
induced with 1 mM isopropyl-β-D-thiogalactoside for 1 h
at 37°C and the His-tagged recombinant peptide was
purified using nickel-nitrilotriacetate agarose column
(Qiagen, Valencia, CA, U.S.A). To avoid baseline expres-
sion of the protein prior to induction, 1% glucose was
maintained in the bacterial medium and the induction
time was kept to a minimum (1 h) to minimize the toxic
effects of the peptide on E. coli. The peptide was dialyzed
extensively against 10 mM sodium phosphate (pH 7.4) to
remove urea.
Transmission electron microscopy
E. coli resuspended in 10 mM sodium phosphate buffer
(pH 7.4) were treated with 50 µg/ml HE2α, HE2β1 or
HE2β2 for 30 and 60 min. After incubation, bacterial cells
were washed with 10 mM sodium phosphate buffer (pH
7.4) and fixed with an equal volume of 4% glutaraldehyde
in 0.1 M sodium cacodylate buffer, pH 7.4, followed by
centrifugation at 1000 rpm for 10 minutes to concentrate
the cells in a pellet. The fixed samples were stored over-
night to several days at 4°C in the fixative solution. The
pellet was rinsed in 0.1 M sodium cacodylate buffer sev-
eral times, and post-fixed with a combination of 1.25%Reproductive Biology and Endocrinology 2004, 2:61 http://www.rbej.com/content/2/1/61
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potassium ferrocyanide and 1% buffered osmium tetrox-
ide for one hour at room temperature. Following dehydra-
tion with a graded series of ethanols (30–100%) and two
changes of propylene oxide, the cell pellet was infiltrated
and embedded in PolyBed 812 epoxy resin (Polysciences,
Inc., Warrington, PA). Ultra thin sections (70 nm) were
cut and mounted on copper grids followed by post stain-
ing with 4% uranyl acetate and 0.4% lead citrate. The sec-
tions were examined and photographed at an accelerating
voltage of 80 kV using a LEO EM 910 transmission elec-
tron microscope (LEO Electron Microscopy, Inc., Thorn-
wood, NY) equipped with a Gatan BioScan digital camera
(Gatan, Inc., Pleasanton, CA).
Scanning electron microscopy
The structural changes induced by HE2 peptides on E. coli
were studied using scanning electron microscopy as
described earlier [30]. Bacterial cells suspended in 10 mM
sodium phosphate buffer (pH 7.4) after treating with 50
µg/ml of HE2 peptide were fixed with an equal volume of
4% glutaraldehyde in 0.15 M sodium phosphate buffer,
pH 7.4. Immediately following the addition of the fixative
solution, the sample tube was mixed by gently inverting
the tube up and down for several minutes to prevent
clumping of the cells. The fixed samples were stored over-
night to several days at 4°C in the fixative solution. Using
a microanalysis vacuum filter holder (Fisher Scientific,
Suwanee, GA) and a 0.1 µm polycarbonate membrane fil-
ter (Poretics Corporation, Livermore, CA), the suspended
fixed cells were vacuum-filtered onto the membrane sub-
strate, rinsed with 0.15 M sodium phosphate buffer, and
dehydrated through a graded series of ethanols (30–
100%). During the entire filtration, rinsing, and dehydra-
tion process, the cells were kept covered with fluid to pre-
vent air drying. The filters were transferred in 100%
ethanol to a critical point dryer (Balzers CPD-020, Bal-Tec
AG, Vaduz, Liechtenstein), and dried using carbon diox-
ide as the transition solvent. The filters were mounted on
aluminum specimen supports with carbon adhesive tabs,
and coated with a 15 nm thickness of gold-palladium
metal (60:40 alloy) using a Hummer X sputter coater
(Anatech, Ltd., Alexandria, VA). Samples were examined
with a Cambridge Stereoscan 200 scanning electron
microscope (LEO Electron Microscopy, Inc., Thornwood,
NY) using an accelerating voltage of 20 kV.
Macromolecular synthesis
The effects of HE2 peptides on E. coli DNA, RNA and pro-
tein synthesis were studied as functions of incorporation
of the radioactive precursors [methyl-3H]thymidine, [5-
3H]uridine and L-[4,5-3H(N)]leucine respectively as
described [30]. 1 × 106 mid-log phase E. coli resuspended
in 10 mM sodium phosphate buffer (pH 7.4) were treated
with varying concentrations of HE2 peptides and 2.5 µl/
ml of either [methyl-3H]thymidine (20 Ci/mmol), [5-
3H]uridine (25.5 Ci/mmol) or L-[4,5-3H(N)]leucine
(59.5 Ci/mmol) for different time periods. After incuba-
tion, bacterial suspensions were added to 10% ice-cold
trichloroacetic acid and allowed to stand in ice for 40 min.
Samples were then collected on 2.4 cm GF/C glass micro-
fiber filters (Fisher Scientific, Pittsburgh, PA) using vac-
uum filtration and washed thoroughly with 5% TCA and
70% ethanol. The filters were then dried and placed in
scintillation vials containing 5 ml of EcoScint scintillation
cocktail (National Diagnostics, Atlanta, GA) and counts
were obtained in a LKB 1214 Rackbeta liquid scintillation
counter (LKB WALLACE, Turku, Finland) for 1 min for
each filter. Statistical analyses using Student's t-test were
performed using Sigma Plot software (SPSS Inc., Chicago,
IL). Values shown are Mean ± S.D.
Amino acid sequence alignment of epididymal HE2 peptides with human β-defensins 1 and 2 Figure 1
Amino acid sequence alignment of epididymal HE2 peptides with human β-defensins 1 and 2. Amino acid sequence shown in 
blue corresponds to the C-terminal peptides used in this study. The characteristic β-defensin six cysteine motif is represented 
in red.   represents the cleavage site where the full length proteins are cleaved to release the C-terminal peptides.
DEFB1                                           GNFLTGLGHRSDHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK
DEFB2   GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP
     
HE2E1 RHVNHSATEALGELRERAPGQGTNGFQLLRHAVKRDLLPPRTPPYQGDVPPGIRNTIC
                                                 
RMQQGICRLFFCHSGEKKRDICSDPWNRCCVSNTDEEGKEKPEMDGRSGI
  
HE2E2 RHVNHSATEALGELRERAPGQGTNGFQLLRHAVKRDLLPPRTPPYQGDVPPGIRNTIC
                                                 
RMQQGICRLFFCHSGTGQQHRQRCG
HE2DRHVNHSATEALGELRERAPGQGTNGFQLLRHAVKRDLLPPRTPPYQVHISHREARGPSFRIC

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Results
Transmission electron microscopy
Transmission electron microscopy revealed striking struc-
tural alterations in E. coli exposed to HE2 peptides. The
three images shown for each treatment were documented
in different fields of view and are intended to represent
the range of responses seen in the bacteria. In contrast to
the smooth continuous double membrane structure
clearly visible in untreated bacteria (Fig. 2A,2B,2C), the
outer membranes of bacteria treated with 50 µg/ml HE2α
peptide for 30–60 min showed thickening and the protru-
sion of irregular blebs. The inner membrane was indis-
tinct in many regions after 30 min and the cytoplasm was
retracting from the outer membrane (Fig. 3A,3B,3C). After
60 min of HE2α treatment, the inner membrane was dif-
ficult to discern and fibrous and granular material, pre-
sumably cell contents appeared to exude from the
damaged membranes (Fig. 3D,3E,3F). Treatment with 50
µg/ml HE2β1 peptide for 30 min resulted in numerous
mushroom shaped blebs and retraction of cytoplasm (Fig.
4A,4B,4C) and by 60 min, these bacteria appeared to lose
cell contents particularly at the division septa (Fig.
4D,4E,4F). Similarly, the HE2β2-treated bacteria showed
loss of the double membrane structure, formation of
blebs and outer membrane roughening (Fig. 5A,5B,5C).
By 60 min, numerous large vacuoles accumulated, the
cytoplasm was extensively granulated and retracted from
the outer membrane and cell contents appeared to escape
at division septa (Fig. 5D,5E,5F). The peptides appeared
to induce structural changes specific to each peptide
besides the morphological changes that were generally
observed. HE2α peptide caused membrane thickenings,
which was not observed with the other two peptides. Sim-
ilarly, HE2β1 peptide caused retraction of cytoplasm
when treated for 30 min, whereas HE2β2 peptide induced
retraction of cytoplasm after 60 min incubation. Forma-
tion of vacuoles was more evident upon treating E. coli
with HE2β2 peptide.
Transmission electron micrographs of untreated E. coli show- ing a smooth continuous double membrane structure Figure 2
Transmission electron micrographs of untreated E. coli show-
ing a smooth continuous double membrane structure.
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E. coli treated with 50 µg/ml HE2α peptide for 30 min (A-C) and 60 min (D-F) visualized by transmission electron microscopy  showed membrane thickening and blebbing with subsequent leakage of cellular contents Figure 3
E. coli treated with 50 µg/ml HE2α peptide for 30 min (A-C) and 60 min (D-F) visualized by transmission electron microscopy 
showed membrane thickening and blebbing with subsequent leakage of cellular contents.
30 min                               60 min
A                                     D
B                                     E
C                                     FReproductive Biology and Endocrinology 2004, 2:61 http://www.rbej.com/content/2/1/61
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Transmission electron micrographs showing cytoplasmic retraction and extensive granulation of E. coli treated with 50 µg/ml  HE2β1 peptide for 30 min (A-C) and 60 min (D-F) Figure 4
Transmission electron micrographs showing cytoplasmic retraction and extensive granulation of E. coli treated with 50 µg/ml 
HE2β1 peptide for 30 min (A-C) and 60 min (D-F).
30 min                        60 min
A                                    D
B                                    E
C                                     FReproductive Biology and Endocrinology 2004, 2:61 http://www.rbej.com/content/2/1/61
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Incubation of E. coli with 50 µg/ml HE2β2 peptide for 30 min (A-C) and 60 min (D-F) show discontinuous membrane structure  with extensive vacuole formation Figure 5
Incubation of E. coli with 50 µg/ml HE2β2 peptide for 30 min (A-C) and 60 min (D-F) show discontinuous membrane structure 
with extensive vacuole formation. Cellular contents appear to leak at the dividing septa.
30 min                          60 min
A                                     D
B                                    E
C                                     FReproductive Biology and Endocrinology 2004, 2:61 http://www.rbej.com/content/2/1/61
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Scanning electron microscopy
E. coli treated with HE2 peptides were observed using
scanning electron microscopy to gain further insights into
the membrane effects. The three images shown for each
treatment were documented in different fields of view and
are intended to represent the range of responses seen in
the bacteria. Untreated bacterial cells had normal and
smooth surface morphology (Fig. 6A,6B,6C). Bacteria
treated with HE2α (Fig. 7A,7B,7C,7D,7E,7F), HE2β1 (Fig.
8A,8B,8C,8D,8E,8F) or HE2β2 (Fig. 9A,9B,9C,9D,9E,9F)
peptides showed pronounced changes in their morphol-
ogy consistent with the changes observed using transmis-
sion electron microscopy. E. coli treated with the HE2
peptides for 30–60 min showed pronounced wrinkling,
surface roughening and blebbing of the membrane. A
majority of the cells appeared to have lost their bacterial
membrane integrity. The fibrous material and cellular
debris, possibly arising due to leakage and cell lysis accu-
mulated particularly at the dividing septa.
Macromolecular synthesis
To investigate whether HE2 peptides affect macromolecu-
lar synthesis of E. coli, the incorporation of radioactive
precursors viz [methyl-3H]thymidine, [5-3H]uridine and
L-[4,5-3H(N)]leucine into DNA, RNA and protein was
studied in the presence of 2–25 µg/ml peptides. A dose
and time dependent inhibition of DNA synthesis by
HE2α peptide was observed (Fig. 10A). 2 µg/ml HE2α
peptide inhibited DNA synthesis after 60 min incubation,
whereas 10 and 25 µg/ml significantly inhibited DNA syn-
thesis after 20 min incubation (Fig. 10A). RNA synthesis
was not inhibited by 2 µg/ml HE2α peptide, whereas inhi-
bition was observed with 10 and 25 µg/ml concentrations
(Fig. 10B). No significant inhibition of protein synthesis
by HE2α peptide was observed at any of the concentra-
tions tested (Fig. 10C).
In the case of HE2β1 peptide, 2 µg/ml dose did not inhibit
DNA synthesis, whereas 10 and 25 µg/ml concentrations
showed significant inhibition (Fig. 11A) after a 20 min
incubation. Similarly, significant inhibition of RNA syn-
thesis was not observed with 2 µg/ml. However, 10 and 25
µg/ml concentrations inhibited RNA after 20 min (Fig.
11B) and protein synthesis (Fig. 11C) after a 60 min
incubation.
Inhibition of E. coli DNA synthesis by HE2β2 peptide was
dose and time dependent. Significant inhibition of DNA
synthesis was observed after a 60 min incubation with 2
µg/ml HE2β2 peptide, whereas the inhibition was
observed at a earlier time point with 10 and 25 µg/ml con-
centrations (Fig. 12A). However, RNA synthesis was not
inhibited by 2 µg/ml HE2β2 peptide, whereas 10 and 25
µg/ml doses were effective after 40 and 10 min incuba-
tions respectively (Fig. 12B). Protein synthesis was inhib-
Scanning electron micrographs of untreated E. coli revealing a  smooth membrane surface morphology Figure 6
Scanning electron micrographs of untreated E. coli revealing a 
smooth membrane surface morphology.
A
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E. coli treated with 50 µg/ml HE2α peptide for 30 min (A-C) and 60 min (D-F) visualized by scanning electron microscopy show  membrane blebbing and leakage of cellular contents Figure 7
E. coli treated with 50 µg/ml HE2α peptide for 30 min (A-C) and 60 min (D-F) visualized by scanning electron microscopy show 
membrane blebbing and leakage of cellular contents.
30 min                           60 min
A                                    D
B                                    E
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Membrane wrinkling and blebbing were evident in E. coli treated with 50 µg/ml HE2β1 peptide for 30 min (A-C) and 60 min (D- F) Figure 8
Membrane wrinkling and blebbing were evident in E. coli treated with 50 µg/ml HE2β1 peptide for 30 min (A-C) and 60 min (D-
F).
30 min                           60 min
A                                    D
B                                    E
C                                    FReproductive Biology and Endocrinology 2004, 2:61 http://www.rbej.com/content/2/1/61
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Scanning electron micrographs of E. coli treated with 50 µg/ml HE2β2 peptide for 30 min (A-C) and 60 min (D-F) Figure 9
Scanning electron micrographs of E. coli treated with 50 µg/ml HE2β2 peptide for 30 min (A-C) and 60 min (D-F). Loss of bac-
terial membrane integrity due to surface blebbing and wrinkling was evident.
30 min                           60 min
A                                    D
B                                    E
C                                    FReproductive Biology and Endocrinology 2004, 2:61 http://www.rbej.com/content/2/1/61
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Effect of HE2α peptide on macromolecular synthesis in E. coli Figure 10
Effect of HE2α peptide on macromolecular synthesis in E. coli. A, [methyl-3H]thymidine incorporation into DNA. B, [5-3H]uri-
dine incorporation into RNA. C, L-[4,5-3H(N)]leucine incorporation into proteins. 0 µg/ml (■ ); 2 µg/ml (▲ ); 10 µg/ml (▼ ); 25 
µg/ml (◆ ). Values shown are mean ± SD. *, P < 0.05-0.01, **, P < 0.01-0.001, ***, P < 0.001 compared to 0 µg/ml at the corre-
sponding time point.
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Effect of HE2β1 peptide on macromolecular synthesis in E. coli Figure 11
Effect of HE2β1 peptide on macromolecular synthesis in E. coli. A, [methyl-3H]thymidine incorporation into DNA. B, [5-3H]uri-
dine incorporation into RNA. C, L-[4,5-3H(N)]leucine incorporation into proteins. 0 µg/ml (■ ); 2 µg/ml (▲ ); 10 µg/ml (▼ ); 25 
µg/ml (◆ ). Values shown are mean ± SD. *, P < 0.05-0.01, **, P < 0.01-0.001, ***, P < 0.001 compared to 0 µg/ml at the corre-
sponding time point.
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ited only with 10 and 25 µg/ml HE2β2 peptide after a 60
min incubation (Fig. 12C). It appears that HE2 peptides
inhibit DNA synthesis to a greater extent than RNA and
protein synthesis, suggesting that DNA synthesis may be
the sensitive target for antimicrobial action after mem-
brane permeabilization.
Discussion
Earlier we demonstrated that HE2 proteins and their C-
terminal peptides exhibit salt tolerant and structural
dependent antimicrobial activities and their mechanism
involved permeabilization of both outer and inner bacte-
rial membranes [29]. In this study, structural changes
induced in E. coli by epididymal HE2α, HE2β1 and
HE2β2 peptides as visualized by transmission and scan-
ning electron microscopy provide further evidence of the
membrane dependent mechanism of bacterial killing.
Such structural changes induced in E. coli by other antimi-
crobial proteins and peptides were reported previously.
Membrane thickening as shown in Fig 3A,3B,3C,3D,3E,3F
was reported in E. coli treated with human neutrophil pep-
tides 1 and 2 (defensins) [14]. Similarly, retraction of
cytoplasm and the appearance of vacuoles as shown in Fig
4A,4B,4C,4D,4E,4F were reported for E. coli treated with
synthetic peptides of the antimicrobial protein apolipo-
protein A-II [31]. Highly granular cytoplasm with discon-
tinuous membrane was reported for E. coli treated with
the antimicrobial peptide tigerinin-1 [32] similar to the
changes shown in Fig. 5A,5B,5C,5D,5E,5F. Scanning elec-
tron micrographs of E. coli treated with HE2 peptides also
revealed striking structural changes in their morphology.
HE2 peptides caused membrane wrinkling, blebbing and
leakage of fibrous material primarily at the dividing septa
in E. coli. Such structural changes shown in Fig. 7,8,9 were
earlier reported for other antimicrobial proteins viz the
cathelicidin-derived peptide SMAP-29 [33], temporin-L
[34], salmon antimicrobial protein [35] and the epididy-
mal proteins ESC42 (DEFB118) [30] and EPPIN [36]. An
interesting observation in this study is the leakage of
fibrous material primarily at the dividing septa. It is
known that cell division in E. coli involves annular
constriction of all layers of the cell envelope and synthesis
and assembly of new septal materials [37]. It is possible
that during this dynamic remodeling process, the region
of division septum formation to be particularly vulnera-
ble to attack by antibacterial proteins.
The mechanism of action of antimicrobial proteins is pri-
marily thought to be membrane dependent involving
membrane permeabilization and disruption. Structural
characteristics of antimicrobial peptides tend to play an
important role in their mechanism of action. For example,
β-defensins are cationic in nature and with β-sheet rich
amphipathic structures stabilized by the three disulfide
motif [38]. The cationic nature of β-defensins favors them
to bind to and disrupt target membranes that are rich in
anionic phospholipids. Similarly, HE2α, HE2β1 and
HE2β2 peptides are cationic in nature with basic pIs. Our
three dimensional structural analysis of HE2β1 peptide
revealed that it is rich in β-sheet structure and its tertiary
structure presents regional concentrations of basic and
hydrophobic amino acids similar to β-defensins [29].
Such structural characteristics of HE2 peptides which
resemble to those of β-defensins suggest that they bind to
and disrupt the anionic target membranes and mediate
bacterial killing similar to β-defensins. However, alternate
mechanisms of antimicrobial action such as inhibition of
macromolecular synthesis [10-12] and interaction with
specific targets inside the bacterial cells [13,14] are pro-
posed. HE2 peptides at 10 and 25 µg/ml concentrations
inhibited DNA, RNA and protein synthesis suggesting that
their antimicrobial action may include interference with
metabolic functions of E. coli. Inhibition of macromolecu-
lar synthesis was reported for bactenectins [39], human
neutrophil peptide-1 [40], pleurocidin derived peptides
[41] and the epididymal defensin DEFB118 [30]. In this
study, it appears that HE2 peptides were more effective in
inhibiting the incorporation of [methyl-3H]thymidine
than [5-3H]uridine and L-[4,5-3H(N)]leucine, suggesting
DNA synthesis is more sensitive to their antimicrobial
action. It is possible that in bacteria that are extensively
damaged by HE2 peptides, inhibition of macromolecular
synthesis may result simply from the total breakdown of
the cells. However the electron micrographs show that
only some bacteria appear to be exuding cell contents
after the 30 minute treatment. Thus during the first 10–20
minutes exposure to HE2 peptides, some peptides may be
entering through pores too small for major cytoplasmic
release. The early inhibition of DNA and RNA synthesis in
bacteria where little loss of cell contents has occurred, may
result from specific interaction of the synthetic machinery
with HE2 peptides. Further studies are required to identify
specific molecular targets within the bacteria and to estab-
lish whether HE2 interactions with these targets can be
beneficial to the host by slowing bacterial proliferation.
Increasing recognition of the ability of a number of pro-
teins on the sperm surface to kill bacteria has led to the
proposal that they may defend against microbial attack in
both the male and female reproductive tracts. The catheli-
cidin hCAP18 on sperm is processed by the prostate-
derived protease, gastricsin to release the active peptide
ALL-38 and is found in the female reproductive tract after
intercourse [42]. A member of the β-defensin family,
DEFB126 also appears to have a role in fertility as a capac-
itation factor on sperm [43]. Similarly, the rat epididymis
specific β-defensin Bin1b, appears to play an important
role in sperm maturation [44]. Thus, these defense pro-
teins may enhance the probability of successful fertiliza-Reproductive Biology and Endocrinology 2004, 2:61 http://www.rbej.com/content/2/1/61
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Effect of HE2β2 peptide on macromolecular synthesis in E. coli Figure 12
Effect of HE2β2 peptide on macromolecular synthesis in E. coli. A, [methyl-3H]thymidine incorporation into DNA. B, [5-3H]uri-
dine incorporation into RNA. C, L-[4,5-3H(N)]leucine incorporation into proteins. 0 µg/ml (■ ); 2 µg/ml (▲ ); 10 µg/ml (▼ ); 25 
µg/ml (◆ ). Values shown are mean ± SD. *, P < 0.05-0.01, **, P < 0.01-0.001, ***, P < 0.001 compared to 0 µg/ml at the corre-
sponding time point.
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tion in addition to helping prevent the spread of sexually
transmitted diseases.
Conclusions
In conclusion, we report that the epididymal antimicro-
bial peptides HE2α, HE2β1 and HE2β2 induce striking
morphological changes in E. coli consistent with their
membrane dependent mechanism of action [29]. In addi-
tion to membrane permeabilization, their antimicrobial
mechanism involves inhibition of E. coli DNA, RNA and
protein synthesis.
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